Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member’s name and school(s) appointments at The University of Texas Health Science Center at Houston, project title, contracting or granting agency, and funding amount.

New

Benjamin C. Amick III, School of Public Health (SPH), International Research Training Program in Trauma and Injury Prevention, National Institutes of Health (NIH), $764,875.

Ben J. Barnett, Medical School (MS), Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTOR-E2), Schering-Plough Corporation, $46,914; and Vicriviroc (SCH 417690) in Combination Treatment with Optimized ART Regimen in Experienced Subjects (VICTORE1), Schering-Plough Corporation, $45,692.

Michael C. Braun, MS, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM) and Graduate School of Biomedical Sciences (GSBS), C3AR and C5AR Modulate T-Cell Responses in the MRL Mouse, NIH, $1,506,217.

Pramod Dash, MS and GSBS, Prefrontal Cortex and Memory Storage, NIH, $1,577,815.

Herbert L. DuPont, SPH and GSBS, A Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Prulifloxacin Versus Placebo in the Treatment of Adults with Acute Gastroenteritis in Travelers Protocol OPT-099-001, Phase 3, Advanced Biologics, $2,002,163.

Charles D. Ericsson, MS, A Double-Blind, Randomized, Controlled Trial of Rifaximin Compared to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea, Salix Pharmaceuticals, $40,713.

Catherine M. Flaitz, Dental Branch (DB), Reuteri Luxs in Probiosis for Early Childhood Caries, Baylor College of Medicine, $15,586.

Gary N. Frey, DB,Wear Resistance of Pediatric Esthetic Crowns, Nusmile Primary Crowns, $8,000.

John Grabowski, MS, SBIRT Program - Screening, Brief Intervention, Referral and Treatment Program, Harris County Hospital District, $162,072.

Adelaide A. Hebert, MS, A Multicenter, Open-Label Study of the Safety and Efficacy of Repeated Treatments with Botox (Botulinum Toxin Type A) Purified Neurotoxin Complex for Primary Axillary Hyperhidrosis in Adolescents, Allergan Inc., $157,596; and A 7 Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of 1% and 2% Nanocrystalline Silver Cream (NPI 32101) Applied Twice Daily in Pediatric and Adolescent Subjects with Mild to Moderate Atopic Dermatitis, Nucryst Pharmaceuticals Inc., $78,820.

James E. Hixson, SPH, Gene-Environment Interactions in Human Parturition Project 1 - Population Structure of Genetic Variation in Pregnancy, University of California - Irvine, $183,482.

Bruce C. Kone, MS and GSBS, Ryan White Title III: Department of General Medicine, Harris County Hospital District, $4,526.

Jary M. Lesser, MS, Phase 3 Multicenter, Randomized, Double- Blind, Placebo Controlled Study of the Effect of Daily Treatment with MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type, PPD Development, LP, $128,830.

Kevin A. Morano, MS and GSBS, HSP110 Protein Chaperone Function in Yeast, NIH, $1,390,118.

Steven J. Norris, MS and GSBS, Global Analysis of Treponema Pallidum Antigens, NIH, $145,458.

Hope Northrup, MS and GSBS, Spina Bifida: Cognitive and Neurobiological Variability, University of Houston, $585,856.

Rade Paravina, DB and GSBS, Data Assessment of Color of Primary Teeth, Nusmile Primary Crowns, $2,000.

Lisa A. Pompeii, SPH, Back Pain and Work Disability in Health Care Workers, Centers for Disease Control and Prevention, $114,843.

Ronald Portman, MS, A Dose-Ranging Study to Evaluate the Safety and Efficacy of Olmesartan Medoxomil in Children and Adolescents with Hypertension, Sankyo Pharma Inc., $284,153.

Belinda M. Reininger, SPH, Cancer Information in the Lower Rio Grande Valley, UT M. D. Anderson Cancer Center, $189,002.

Shyang-Yun P. Shiao, School of Nursing, Effects of Obesity on Vagal Tone and HBA1c During Pregnancy, NIH, $74,272.

Thomas H. Stock, SPH, Air Monitoring for Improving Environmental Quality Through Collaboration, Mothers for Clean Air, $31,252.

Karen Adler Storthz, DB and GSBS, Characterization of Functional Interaction Between PIT X2, LEF-1, and B-Catenin, International Association for Dental Research, $3,000.

Rita D. Swinford, MS, IGF-I Generation Test in Children with Chronic Kidney Disease, Oregon Health Sciences University, $27,500.

Charles T. Van Buren, MS, A Randomized, Open-Label, Comparative Evaluation of the Safety and Efficacy of Sirolimus Versus Cyclosporine when Combined in a Regimen Containing Basiliximab, Mycophenolate Mofetil, and Corticosteroids in Primary De Novo Renal Allograft Recipients, Wyeth Pharmaceuticals, $672,438.

Sally W. Vernon, SPH, Home Telehealth Reminders to Improve Colonoscopic Prep and Reduce No Shows, Veterans Administration Medical Center, $21,331.

Scott T.Walters, SPH, Dismantling Motivational Interviewing and Feedback for College Drinkers, NIH, $564,750.

Run Wang, MS, Clinical Study to Evaluate the Ability of Muse to Decrease Erectile Function Recovery Time in Post Radical Prostatectomy Patients, Vivus Inc., $117,634.

Ouida L.Westney, MS, A Multicenter, Open Label, Active- Controlled, Dose Titration Study Evaluating the Safety, Efficacy and Pharmacokinetics of Oxybutynin Transdermal Systems in the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Patients,Watson Laboratories Inc., $100,020.

Renewal

Ralph F. Frankowski, SPH, North American Clinical Trials Network for the Treatment of Spinal Cord Injury, Christopher Reeves Paralysis Foundation, $191,388.

Mary M. Velasquez, MS, Screening Brief Intervention Referral and Treatment Project (SBIRT), Texas Department of State Health Services, $319,321.

Willy Wriggers, School of Health Information Sciences, IMM and GSBS, Multi-Resolution Docking Methods for Electron Microscopy, NIH, $1,128,600.